Interestingly, our study illustrated that CCNA2 could enhance the development of ccRCC via several immune-related signals, including immunodeficiency, natural killer cell-mediated cytotoxicity pathway, and IL6-JAK-STAT3 pathways. The gene discussed is CCNA2; the disease is nonpapillary renal cell carcinoma.